Provided by Tiger Fintech (Singapore) Pte. Ltd.

Instil Bio, Inc.

23.41
-0.5900-2.46%
Volume:227.92K
Turnover:5.34M
Market Cap:153.57M
PE:-1.96
High:24.44
Open:23.63
Low:22.54
Close:24.00
Loading ...

Instil Bio Inc. Conducted Annual Stockholders Meeting

Reuters
·
29 May

Instil Bio Advances Phase 2 Trial in China

TIPRANKS
·
28 May

Instil Bio Announces Upcoming Phase 3 Trial of '2510 in Combination with Chemotherapy for First-Line NSCLC in China, Set to Begin Mid-2026

Reuters
·
28 May

Citizens JMP Reaffirms Their Hold Rating on Instil Bio (TIL)

TIPRANKS
·
27 May

Instil Bio price target raised to $125 from $105 at H.C. Wainwright

TIPRANKS
·
23 May

Instil Bio Shares Jump on Trial Updates for Lung Cancer Treatment

Dow Jones
·
23 May

Instil Bio, ImmuneOnco Say Lung Cancer Drug `2510 Mid-Stage Trial Enrollment in China on Track for Q3

MT Newswires Live
·
22 May

Instil Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
22 May

ADVISORY-Alerts incorrectly tagged to T Rowe Price Large-Cap Value Fund withdrawn

Reuters
·
22 May

Immuneonco Biopharmaceuticals Announces New Clinical Trial Updates for IMM2510/AXN-2510 in First-Line NSCLC Treatment

Reuters
·
22 May

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Motley Fool
·
21 May

Instil Bio Q1 Adj. EPS $(1.32) Beats $(2.59) Estimate

Benzinga
·
13 May

Instil Bio Inc. Reports Increased Net Loss Per Share and Reduced Non-GAAP Net Loss Per Share in Q1 2025 Results

Reuters
·
13 May

BRIEF-Instil Bio Q1 Basic EPS USD -4.32

Reuters
·
13 May

3 Monster Stocks in the Making

Motley Fool
·
11 May

Instil Bio Inc expected to post a loss of $2.59 a share - Earnings Preview

Reuters
·
06 May

My 3 Favorite Stocks to Buy Right Now

Motley Fool
·
06 May

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025

GlobeNewswire
·
03 May

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

GlobeNewswire
·
26 Apr

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

GlobeNewswire
·
24 Apr